Spontaneous subcapsular splenic hematoma associated with filgrastim in a patient undergoing allogeneic hematopoietic stem cell transplantation

Annals of Pharmacotherapy

Volumn 47, Issue 5, 2013, Pages

  Ganetsky, Alex ^a   Kucharczuk, Colleen ^a   Del Percio, Sarah ^a   Frey, Noelle ^a   Gill, Saar ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AZACITIDINE; BUSULFAN; CYCLOPHOSPHAMIDE; FLUCONAZOLE; FLUDARABINE; LENALIDOMIDE; OPIATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOPSY; BONE MARROW BIOPSY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DRUG MEGADOSE; ELECTROCARDIOGRAPHY; FEMALE; HEART INFARCTION; HUMAN; MYCOSIS; MYELODYSPLASTIC SYNDROME; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; RESUSCITATION; SHOULDER PAIN; SPLEEN HEMATOMA; SPLENECTOMY; SPONTANEOUS SUBCAPSULAR SPLENIC HEMATOMA; THORAX PAIN; TREATMENT RESPONSE; VIRUS INFECTION;

EID: 84877099964     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1S005     Document Type: Article

References (22)

1. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med 2006;354:1813-26.
2. Wingard JR, Hsu J, Hiemenz JW. Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology. Infect Dis Clin North Am 2010;24:257-72.
3. Bishop MR, Tarantolo SR, Geller RB, et al. A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation. Blood 2000;96:80-5.
4. Lieschke GJ, Burhess AW. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N Engl J Med 1992; 327:28-35.
5. Package insert. Neupogen (filgrastim). Thousand Oaks, CA: Amgen, May 2012.
6. Battiwalla M, McCarthy PL. Filgrastim support in allogeneic HSCT for myeloid malignancies: a review of the role of G-CSF and the implications for current practice. Bone Marrow Transplant 2009;43:351-6.
7. Trivedi M, Martinez S, Corringham S, Medley K, Ball ED. Optimal use of G-CSF administration after hematopoietic SCT. Bone Marrow Transplant 2009;43:895-908.
8. Khoury HJ, Loberiza FR, Ringden O, et al. Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation. Blood 2006;107:1712-6.
9. Ringden O, Labopin M, Gorin NC, et al. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol 2004;22:416-23.
10. Liesveld J, Pawlowski J, Chen R, et al. Clinical factors affecting engraftment and transfusions needs in SCT: a single-center retrospective analysis. Bone Marrow Transplant Epub 22 Oct 2012.
11. Ringden O, Hassan Z, Karlsson H, et al. Granulocyte colony-stimulating factor induced acute and chronic graft-versus-host disease. Transfusion 2010;90:1022-9.
12. D'Souza A, Jaiyesimi I, Trainor L, Venuturumili P. Granulocyte colonystimulating factor administration: adverse events. Transfusion Med Rev 2008;22:280-90.
13. Nuamah NM, Goker H, Kilic Y, Dagmoura H, Cakmak A. Spontaneous splenic rupture in a healthy allogeneic donor of peripheral-blood stem cell following the administration of granulocyte colony-stimulating factor (GCSF). A case report and review of the literature. Haematologica 2006;91: e26-8.
14. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30: 239-45.
15. Aubrey-Bassler FK, Sowers N. 613 cases of splenic rupture without risk factors or previously diagnosed disease: a systematic review. BMC Emerg Med 2012;12:11.
16. Hatzimichael E, Benetatos L, Stebbing J, Kapsali E, Panayiotopoulou S, Bourantas KL. Spontaneous splenic haematoma in a multiple myeloma patient receiving pegfilgrastim support. Clin Lab Haematol 2006;28:416-8.
17. Stroncek DF, Dittmar K, Shawker T, Heatherman A, Letiman SF. Transient spleen enlargement in peripheral blood progenitor cell donors given G-CSF. J Translatio Med 2004;2:1-4.
18. Kasper C, Jones L, Fujita Y, Morgenstern GR, Scarffe JH, Chang J. Splenic rupture in a patient with acute myeloid leukemia undergoing peripheral blood stem cell transplantation. Ann Hematol 1999;78:91-2.
19. Pitini V, Ciccolo A, Arrigo C, Aloi G, Micali C, La Torre F. Spontaneous rupture of spleen during peripheral blood stem cell mobilization in a patient with breast cancer. Haematologica 2000;85:559-560.
20. O'Malley DP, Whalen M, Banks PM. Spontaneous splenic rupture with fatal outcome following G-CSF administration for myelodysplastic syndrome. Am J Hematol 2003;73:294-5.
21. Arshad M, Seiter K, Bilaniuk J, et al. Splenic rupture following pegfilgrastim. J Clin Oncol 2005;23:8533-4.
22. Renzulli P, Hostettler A, Schoepfer AM, Gloor B, Candinas D. Systematic review of a traumatic splenic rupture. Br J Surg 2009;96:1114-21.